Clinical trial for ADHD
Official title Digital Health Intervention for Children With ADHD
ClinicalTrials.gov ID: NCT06456372
What this study is testing
- What it's testing
- This study is testing whether a digital health program delivered on a smartwatch and smartphone helps children with ADHD.
- Who it's for
- You may be able to join if you are 8 to 12 years old and have ADHD.
- What's involved
- You might receive a smartwatch with a special app to use at home, or a smartwatch with no program. You will use it for 16 weeks.
- Time commitment
- The study lasts 16 weeks with a start visit and a final check‑in.
- Time commitment: about 16 weeks
Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 8 to 12
You may be able to join if
- DSM-5TR diagnosis of ADHD through prior medical or psychological evaluations at the time of admission to the program,
- ability to complete questionnaires and use an app in English,
- reported IQ of at least 80 in order to ensure that the participant has the cognitive skills needed to use the app, and
- parent/guardian available to consent and provide feedback in English.
You likely can't join if
- Failure to meet any of the inclusion criteria
The study team makes the final eligibility decision.
Where it is enrolling
- Irvine, California, United States
- Riverside, California, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The study runs about 16 weeks per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 8 years to 12 years. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Irvine, California, United States; Riverside, California, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.